Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Limits on optimizing ocular drug delivery.

J C Keister1, E R Cooper, P J Missel

  • 1Alcon Laboratories, Inc., Fort Worth, TX 76134-2099.

Journal of Pharmaceutical Sciences
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Heat Risk: Comparing On-Site WBGT Measurements Versus Smartphone Application Estimates.

GeoHealth·2025
Same author

The clinical and economic costs associated with regional disparities in varicella vaccine coverage in Italy over 50 years (2020-2070).

Scientific reports·2024
Same author

Reproductive Integration in Reef Corals.

The Biological bulletin·2018
Same author

Unraveling 5f-6d hybridization in uranium compounds via spin-resolved L-edge spectroscopy.

Nature communications·2017
Same author

A muscle-specific protein 'myoferlin' modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus.

Oncogene·2017
Same author

Crystallization of spin superlattices with pressure and field in the layered magnet SrCu2(BO3)2.

Nature communications·2016
Same journal

Enhanced zika virus suppression by coupling ribavirin with biodegradable drug delivery.

Journal of pharmaceutical sciences·2026
Same journal

Immune tolerance platforms to mitigate unwanted immune responses.

Journal of pharmaceutical sciences·2026
Same journal

Green, renewable, or low-carbon? A framework for informed solvent selection in pharmaceutical sciences.

Journal of pharmaceutical sciences·2026
Same journal

Theranostic potential of ramucirumab functionalized magnetoliposomes for targeted delivery of sorafenib and MRI.

Journal of pharmaceutical sciences·2026
Same journal

Intranasal mucoadhesive chitosan microspheres of ranolazine: Formulation, design, and pharmacokinetic evaluation.

Journal of pharmaceutical sciences·2026
Same journal

Evolving landscape of drug development for pediatric rare diseases-from successes to strategies for addressing unmet needs.

Journal of pharmaceutical sciences·2026
See all related articles

Optimizing ophthalmic drug delivery requires understanding ocular bioavailability. High corneal permeability enhances drug absorption, while small dosage volumes significantly improve bioavailability for drugs with low permeability.

Area of Science:

  • Ophthalmology
  • Pharmacokinetics
  • Drug Delivery

Background:

  • Topical ophthalmic drug administration faces challenges in optimizing ocular bioavailability.
  • Efficient drug delivery to the eye is crucial for effective treatment of ocular diseases.

Purpose of the Study:

  • To analyze and optimize ocular bioavailability for topically applied ophthalmic drugs.
  • To establish relationships between drug properties, dosage parameters, and ocular drug absorption.

Main Methods:

  • Derivation of a drug concentration formula in the tear film using pharmacokinetic principles.
  • Application of a first-order drug decay model for tear film dynamics.
  • Relating the time integral of tear film concentration to ocular bioavailability.

Related Experiment Videos

Main Results:

  • Higher corneal permeability, characteristic of lipophilic compounds, significantly enhances ocular bioavailability.
  • Ocular bioavailability for drugs with high corneal permeability is largely independent of the administered drug volume.
  • Reducing dosage volume can yield an approximate fourfold increase in bioavailability for drugs with low corneal permeability.

Conclusions:

  • Corneal permeability is a critical factor influencing ophthalmic drug bioavailability.
  • Dosage volume optimization offers a viable strategy to improve drug absorption, particularly for less permeable drugs.
  • Pharmacokinetic modeling provides valuable insights for enhancing topical ophthalmic drug delivery.